1st Sub.
H.B.
120
INFORMATION ON PHARMACEUTICAL PRODUCTS
House Committee
Amendments
Amendment 2 February 25, 2013 4:44 PM
Representative Paul Ray
proposes the following amendments:
1. Page
2, Lines 37 through 39
:
37
(B) employed by someone other than a pharmaceutical manufacturer
:
(I) for the purpose of countering information provided in commercial detailing; and
(II)
to disseminate
38
educational information about prescription drugs to other health care providers
{
across a broad
39
range of interventions
}
in an effort to better align clinical practice with scientific research; and
2. Page
2, Lines 43 through 45
:
43
higher education or through a medical residency program;
{
or
}
44
(B) is disseminating educational information about a prescription drug to a patient or a
45
patient's representative
; or
(C) is acting within the scope of practice for the health care provider regarding the prescribing or
dispensing of a prescription drug
.
3. Page
2, Line 56
:
56
(i)
{
labeling and
}
false and misleading advertising in 21 C.F.R., Part 201 (2007);
4. Page
3, Line 61
:
61
against
{
the person who violated this section
}
a person engaged in academic detailing, if:
(i) the actions of the person engaged in academic detailing, that are a violation of this section, are:
(A) the result of gross negligence by the person; or
(B) willful and wanton behavior by the person; and
(ii) the damages to the person are proximately caused by the violations of this section.
Page 1 of 1
hb0120s01.hca.02.wpd
LRGC
cdupont
cdupont
S 02/25/13 4:44p